Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants

Vaccine

Volumn 33, Issue 48, 2015, Pages 6793-6799

  Dangor, Ziyaad ^a,b   Kwatra, Gaurav ^a   Izu, Alane ^a   Adrian, Peter ^a   Cutland, Clare L ^a   Velaphi, Sithembiso ^b   Ballot, Daynia ^b   Reubenson, Gary ^b   Zell, Elizabeth R ^c   Lala, Sanjay G ^b   Madhi, Shabir A ^a,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Stat Epi Associates Inc   (United States)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

Antibody; GBS; Group B Streptococcus; Immunity; Streptococcus agalactiae; Vaccine

Indexed keywords

IA ANTIBODY; MATERNAL ANTIBODY; SPECIFIC CAPSULAR ANTIBODY; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; BIOLOGICAL MARKER;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFANT; INFANT DISEASE; INFECTION RISK; LATEX AGGLUTINATION TEST; LOWEST INCOME GROUP; MALE; MATERNAL AGE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEROTYPE; SOUTH AFRICAN; BACTERIAL CAPSULE; BLOOD; IMMUNOLOGY; NEWBORN; PREGNANCY; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84949843702     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.019     Document Type: Article

References (29)

1. Dagnew A.F., Cunnington M.C., Dube Q., Edwards M.S., French N., Heyderman R.S., et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55:91-102.
2. Edmond K.M., Kortsalioudaki C., Scott S., Schrag S.J., Zaidi A.K.M., Cousens S., et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012, 379:547-556.
3. Steinhoff M.C. Assessments of vaccines for prenatal immunization. Vaccine 2013, 31(Suppl. 4):D27-D30.
4. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K., et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014, 384:1521-1528.
5. Madhi S.A., Cutland C.L., Kuwanda L., Weinberg A., Hugo A., Jones S., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014, 371:918-931.
6. Kasper D.L., Paoletti L.C., Wessels M.R., Guttormsen H.K., Carey V.J., Jennings H.J., et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996, 98:2308-2314.
7. Madhi S.A., Dangor Z., Heath P.T., Schrag S., Izu A., Sobanjo-Ter Meulen A., et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 2013, 31(Suppl. 4):D52-D57.
8. Dangor Z., Kwatra G., Izu A., Lala S.G., Madhi S.A. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines 2015, 14:135-149.
9. Mayosi B.M., Benatar S.R. Health and health care in South Africa - 20 years after Mandela. N Engl J Med 2014, 371:1344-1353.
10. Madhi S.A., Radebe K., Crewe-Brown H., Frasch C.E., Arakere G., Mokhachane M., et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr 2003, 23:15-23.
11. Cutland C.L., Schrag S.J., Thigpen M.C., Velaphi S.C., Wadula J., Adrian P.V., et al. Increased risk for Group B Streptococcus Sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008. Emerg Infect Dis 2015, 21:638-645.
12. Dangor Z., Lala S.G., Cutland C.L., Koen A., Jose L., Nakwa F., et al. Burden of invasive group B streptococcus disease and early neurological sequelae in South African infants. PLOS ONE 2015, 10:e0123014.
13. District Research Committee Birth statistics 2014, Johannesburg Health District. Gauteng Department of Health, Johannesburg.
14. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm Rep 2010, 59:1-36.
15. National Department of Health Clinical guidelines: PMTCT (prevention of mother-to-child transmission) 2010, National Department of Health, South Africa, Pretoria.
16. National Department of Health The South African antiretroviral treatment guidelines, PMTCT guidelines: revised March 2013 2013, 8. Department of Health, South Africa.
17. Dangor Z., Kwatra G., Izu A., Adrian P., van Niekerk N., Cutland C.L., et al. HIV-1 is associated with lower group b streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis 2015, 212:453-462.
18. Kwatra G., Adrian P.V., Shiri T., Buchmann E.J., Cutland C.L., Madhi S.A. Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy. PLOS ONE 2014, 9:e98778.
19. Poyart C., Tazi A., Reglier-Poupet H., Billoet A., Tavares N., Raymond J., et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007, 45:1985-1988.
20. Lin F.Y., Philips J.B., Azimi P.H., Weisman L.E., Clark P., Rhoads G.G., et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 2001, 184:1022-1028.
21. Lin F.Y., Weisman L.E., Azimi P.H., Philips J.B., Clark P., Regan J., et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 2004, 190:928-934.
22. Christensen K.K., Christensen P., Duc G., Hoger P., Kind C., Matsunaga T., et al. Correlation between serum antibody-levels against group B streptococci and gestational age in newborns. Eur J Pediatr 1984, 142:86-88.
23. Boyer K.M., Papierniak C.K., Gadzala C.A., Parvin J.D., Gotoff S.P. Transplacental passage of IgG antibody to group B streptococcus serotype Ia. J Pediatr 1984, 104:618-620.
24. Kleinbaum D.G., Klein M. Logistic regression, a self-learning text 2002, Springer, New York. 2nd ed.
25. Carey V.J., Baker C.J., Platt R. Bayesian inference on protective antibody levels using case-control data. Biometrics 2001, 57:135-142.
26. Plummer M. JAGS. A Program for Analysis of Bayesian Graphical Models Using Gibbs Sampling. In: Proceedings of the 3rd International Workshop on Distributed Statistical Computing (Vienna, Austria).
27. Baker C.J., Carey V.J., Rench M.A., Edwards M.S., Hillier S.L., Kasper D.L., et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2014, 209:781-788.
28. Kwatra G., Adrian P.V., Shiri T., Buchmann E.J., Cutland C.L., Madhi S.A. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clin Microbiol Infect 2015, 21:568. e13-21.
29. Anthony B.F., Concepcion I.E., Concepcion N.F., Vadheim C.M., Tiwari J. Relation between maternal age and serum concentration of IgG antibody to type III group B streptococci. J Infect Dis 1994, 170:717-720.